Publications by authors named "Robin E Offord"

Claim this Profile
D
Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTES.
John W McBride, R Karl Malcolm, Nicola Dias, David Cameron, Robin E Offord

Int J Pharm· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES.
John W McBride, Peter Boyd, Nicola Dias, David Cameron, Robin E Offord

J Control Release· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of the Protein Microbicide 5P12-RANTES in Sheep following Single-Dose Vaginal Gel Administration.
John W McBride, Nicola Dias, David Cameron, Robin E Offord, Oliver Hartley

Antimicrob Agents Chemother· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using glycosaminoglycan/chemokine interactions for the long-term delivery of 5P12-RANTES in HIV prevention.
Nick X Wang, Scott F Sieg, Michael M Lederman, Robin E Offord, Oliver Hartley

Mol Pharm· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR5 mutations distinguish N-terminal modifications of RANTES (CCL5) with agonist versus antagonist activity.
Won-Tak Choi, Rebecca Nedellec, Mia Coetzer, Philippe Colin, Bernard Lagane, Robin E Offord

J Virol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use.
Rebecca Nedellec, Mia Coetzer, Michael M Lederman, Robin E Offord, Oliver Hartley

PLoS One· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1 SF162 or simian-human immunodeficiency virus SHIV SF162-p3 do not confer resistance.
Rebecca Nedellec, Mia Coetzer, Michael M Lederman, Robin E Offord, Oliver Hartley

J Virol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemokine analogues show suitable stability for development as microbicides.
Fabrice Cerini, Alan Landay, Carolyne Gichinga, Michael M Lederman, Rebecca Flyckt, Robin E Offord

J Acquir Immune Defic Syndr· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbicides and other topical strategies to prevent vaginal transmission of HIV.
Michael M Lederman, Robin E Offord, Oliver Hartley

Nat Rev Immunol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering chemokines to develop optimized HIV inhibitors.
Oliver Hartley, Robin E Offord

Curr Protein Pept Sci· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes.
Tatsuyoshi Kawamura, Shannon E Bruse, Awet Abraha, Makoto Sugaya, Oliver Hartley, Robin E Offord

J Virol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3.
Yolande Chvatchko, Amanda E I Proudfoot, Raphaële Buser, Pierre Juillard, Sami Alouani, Robin E Offord

J Immunol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines.
Oliver Hartley, Karim Dorgham, Danielle Perez-Bercoff, Fabrice Cerini, Anouk Heimann, Robin E Offord

J Virol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTES.
Cristina Pastore, Gastón R Picchio, Francesco Galimi, Richard Fish, Oliver Hartley, Robin E Offord

Antimicrob Agents Chemother· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis